Iovance Biotherapeutics IOVA
NASDAQ IOVA
$14.14 -0.48 (-3.28%)
At close: Oct 22, 2026 · 4:00 PM EDT

Iovance Biotherapeutics (IOVA) Non Operating Interest Expenses (2011 - 2012)

Updated

Iovance Biotherapeutics' Non Operating Interest Expenses came in at -$5,660 for FY2014, compared with $444,729 in FY2013.

Analysis

Iovance Biotherapeutics (IOVA) Non Operating Interest Expenses (2011 - 2012) Analysis & Trends

  • Per Business Quant, earlier years put Non Operating Interest Expenses at $444,729 in FY2013 and $151,507 in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 217.00 Mn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 462.00 Mn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 435.00 Mn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 247.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Iovance Biotherapeutics 6.36 Bn 5.15 Bn 55.72 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2012 126,924.00
Jun 30, 2012 110,810.00
Mar 31, 2012 88,472.00
Dec 31, 2011 119,863.00
Sep 30, 2011 31,644.00
API Access

Iovance Biotherapeutics Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=IOVA&period=max&api_key=YOUR_API_KEY